Nycomed, a top Norwegian pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years.
Summary
Website: Nycomed
Headquarters: Zurich, Switzerland
Ticker Symbol: Owned Privatley
SEC Link: Nycomed
Premium content
The remaining part of this article is Premium content – see below for access options.
CP Insight – Premium content section
This is a premium content section and requires a paid subscription to access.
Please login to read the full article or take a look at the subscribe page for more information on prices.
LOG IN or CONTACT US
Already a subscriber?
Access to this area requires a CP Insight subscription.Subscription options
View for more information on pricing
Have a question?
